Ac-DNLD-AMC
|
- $28 - $3500
- Product name: Ac-DNLD-AMC
- CAS: 958001-92-8
- MF: C30H38N6O12
- MW: 674.66
- EINECS:
- MDL Number:MFCD07368596
- Synonyms:Ac-DNLD-AMC;AC-DNLD-AMC;CASPASE-3 SUBSTRATE;AC-ASP-ASN-LEU-ASP-MCA;L-α-Asparagine, N-acetyl-L-α-aspartyl-L-asparaginyl-L-leucyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-;N-acetyl-L-α-aspartyl-L-asparaginyl-L-leucyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-L-α-asparagine
4 prices
Selected condition：
Brand
- Cayman Chemical
- DC Chemicals
Package
- 500μg
- 1mg
- 1g
- 5 mg
- ManufacturerCayman Chemical
- Product number24566
- Product descriptionAc-DNLD-AMC ≥95%
- Packaging500μg
- Price$28
- Updated2023-01-06
- Buy
- ManufacturerCayman Chemical
- Product number24566
- Product descriptionAc-DNLD-AMC ≥95%
- Packaging1mg
- Price$36
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number24566
- Product descriptionAc-DNLD-AMC ≥95%
- Packaging5 mg
- Price$162
- Updated2024-03-01
- Buy
- ManufacturerDC Chemicals
- Product numberDC11359
- Product descriptionCaspase-3Substrate >98%
- Packaging1g
- Price$3500
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Cayman Chemical | 24566 | Ac-DNLD-AMC ≥95% | 500μg | $28 | 2023-01-06 | Buy |
| Cayman Chemical | 24566 | Ac-DNLD-AMC ≥95% | 1mg | $36 | 2024-03-01 | Buy |
| Cayman Chemical | 24566 | Ac-DNLD-AMC ≥95% | 5 mg | $162 | 2024-03-01 | Buy |
| DC Chemicals | DC11359 | Caspase-3Substrate >98% | 1g | $3500 | 2021-12-16 | Buy |
Properties
Boiling point :1211.3±65.0 °C(Predicted)
Density :1.402±0.06 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :Formic Acid: 1 mg/ml
form :A lyophilized powder
pka :4.09±0.10(Predicted)
Density :1.402±0.06 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :Formic Acid: 1 mg/ml
form :A lyophilized powder
pka :4.09±0.10(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|